Fig. 1 · Structure
Documents & Downloads
HLX-22
Anti-HER2 Antibody
HLX-22 is a humanized monoclonal antibody that specifically targets HER2, a receptor often overexpressed in certain cancer types. This antibody exhibits significant anti-tumor activity by inducing apoptosis in HER2-overexpressing breast and gastric cancer cells, particularly in combination with Trastuzumab. HLX-22 is primarily utilized in research focused on advanced solid tumors, making it a valuable tool in the study of targeted cancer therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2851060-90-5 |
| Applications | Anti-HER2 Antibody |
| Molecular Weight | 144.18 kDa |
| Synonyms | AC101 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.